UNIVERSITY OF CALIFORNIA, DAVIS
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1905-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ucdavis.edu
Clinical Trials
754
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (623 trials with phase data)• Click on a phase to view related trials
Mango Intake and Gut and Cardiometabolic Health in Hispanic/Latino Adolescents
- Conditions
- Cardiometabolic Health IndicatorsVascular Function in Healthy VolunteersInflammation
- First Posted Date
- 2025-08-15
- Last Posted Date
- 2025-08-15
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 25
- Registration Number
- NCT07125001
Using an AI Mobile Application to Promote Healthy Eating
- Conditions
- Healthy
- First Posted Date
- 2025-08-07
- Last Posted Date
- 2025-08-07
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 114
- Registration Number
- NCT07108452
- Locations
- 🇺🇸
University of California, Davis - Department of Nutrition, Davis, California, United States
Pragmatic Trial of Text Messages to Recruit Unassisted Smokers Into Quitline Service
- Conditions
- Smoking Cessation Counselling
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 4171
- Registration Number
- NCT07102290
- Locations
- 🇺🇸
Kick It California, San Diego, California, United States
Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
- Conditions
- PASC Post Acute Sequelae of COVID-19
- First Posted Date
- 2025-07-22
- Last Posted Date
- 2025-07-22
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 51
- Registration Number
- NCT07076862
- Locations
- 🇺🇸
UC Davis EXPLORER Molecular Imaging Center, Sacramento, California, United States
Intralesional Cyclosporine for Alopecia Areata
- Conditions
- Alopecia Areata
- Interventions
- Drug: CycloSPORINE Injectable ProductDrug: Saline Solution
- First Posted Date
- 2025-06-19
- Last Posted Date
- 2025-06-19
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 12
- Registration Number
- NCT07029204
- Locations
- 🇺🇸
University of California, Davis - Dermatology Department, Sacramento, California, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 151
- Next
News
UC Davis Scientists Develop Non-Hallucinogenic LSD Derivative That Shows Promise for Schizophrenia Treatment
Researchers at UC Davis created JRT, a novel compound derived from LSD by repositioning just two atoms in its molecular structure, potentially offering a breakthrough treatment for schizophrenia without hallucinogenic effects.
Promising Alzheimer's Vaccine Targeting Tau Protein Advances Toward Human Trials
University of New Mexico researchers have developed a vaccine that generates antibodies against pathological tau protein (pT181), showing efficacy in both mice and non-human primates with strong immune responses.
CRISPR-Cas9 Reduces VEGF Levels in Monkeys, Shows Retinal Toxicity at High Doses
CRISPR-Cas9 targeting VEGFA delivered via AAV vectors reduces VEGF levels in monkeys, potentially treating choroidal neovascularisation (CNV).